Key facts
- Notable investors include Shicui Capital, YuanMing Capital.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Fengzhi Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Fengzhi Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Fengzhi Medical
Manufacturer of peripheral vascular interventional systems intended for minimally invasive treatment. The company features a self-developed coating design and replaces the traditional long stent as a remedial use after balloon blood vessel dilation, providing doctors with more precise implantation and simpler operation solutions.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2022
- Ownership
- Privately Held (backing)
Fengzhi Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Fengzhi Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Fengzhi Medical in its N-PORT filings yet. We sweep new filings monthly.